ClinConnect ClinConnect Logo
Search / Trial NCT03475147

Smartphone Flicker Fusion Test for Patients With Optic Disorders.

Launched by RANDY KARDON · Mar 16, 2018

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is testing a new smartphone app called eyeFusion, which helps measure something called "flicker fusion." This is a quick and easy way to assess how well your eyes are functioning, especially for patients with a specific vision problem known as scotoma, where part of the visual field is missing. The goal is to see if this app can be a useful tool for doctors to gather important information about eye health during routine care.

To participate in this study, you should be between 18 and 80 years old. If you have scotoma, you may qualify as a patient. Healthy individuals without any eye disorders can also join as control participants. During the trial, you'll simply use the app to perform the test, which should be straightforward and not take much time. This research might help improve how doctors diagnose and manage optic disorders in the future. If you’re interested, you can reach out to learn more about joining the study!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Control
  • Age matched 18-80 years of age.
  • Healthy normal controls with no known eye disorders.
  • Exclusion Criteria:
  • Scotoma or any other ocular disorder
  • Inclusion Criteria - Patients
  • Age 18-80
  • Clinically associated scotoma
  • Exclusion Criteria - Patients
  • -Any other ocular disorder

About Randy Kardon

Randy Kardon is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in clinical medicine and a focus on innovative therapeutic solutions, he leads initiatives that explore cutting-edge treatments across various health conditions. Under his guidance, clinical trials are conducted with rigorous adherence to ethical standards and regulatory compliance, ensuring the highest quality of data collection and analysis. Randy Kardon’s dedication to collaboration and transparency fosters partnerships with academic institutions, healthcare providers, and industry stakeholders, driving forward the development of safe and effective medical interventions.

Locations

Iowa City, Iowa, United States

Iowa City, Iowa, United States

Patients applied

0 patients applied

Trial Officials

Randy Kardon, MD, PhD

Principal Investigator

University of Iowa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials